Asthma News: Breaking Asthma News, Comments and Articles. - Page: 5

06:47 EST 27th November 2014 | BioPortfolio

Asthma News - Page: 5Twitter RSS

Read the latest Asthma News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Asthma.

Search or Follow Our Asthma - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Asthma - Page: 5 News.
You can also follow our Asthma - Page: 5 news stories on Twitter: @asthma_bio

Showing "asthma" News Articles 101 to 125 of 1,100+

Wednesday 12th November 2014

CareMed Urgent & Primary Care Now Open in the Fairfax Centre Shopping Center

A company with one of the nation’s leading medical care teams has opened for business in an effort to provide timely and cost-effective walk-in medical services to the people of Fairfax, VA, and the greater Washington, DC area. Fairfax, VA (PRWEB) November 12, 2014 Representatives with CareMed Urgent & Primary Care announced today that they’ve officially opened for business in the Fairfax...

Children Often Rate Their Asthma Worse Than Parents Report

The discrepancy between ratings of asthma control by children and their caregivers highlights the need for greater communication and education. Medscape Medical News

Ligand Partner GlaxoSmithKline Announces EU Regulatory Submission for Severe Aplastic Anemia Indication for Revolade™ (eltrombopag)

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner GlaxoSmithKline (GSK) plc reported the submission to the European Medicines Agency (EMA) of a variation to the Marketing Authorization for Revolade™ (eltrombopag), seeking an additional indication for the treatment of adult patients with severe aplastic anemia (SAA) who have ha...

Make the Diagnosis: A Very Old Man with Foot Pain

(MedPage Today) -- Case Study: A ninety-one-year-old man presented with pain, tenderness, and swelling in the right foot and difficulty walking. The patients history included coronary artery disease, non-insulin-dependent diabetes mellitus, osteoarth...

GNS Healthcare and CHDI Foundation collaborate to identify novel drug targets for Huntington’s disease

Scientific team using state-of-the-art technology to analyze vast dataset GNS Healthcare (GNS), a leading provider of big data analytics in health care, announced today that CHDI Foundation, Inc. (CHDI), a privately-funded, nonprofit biomedical research organization exclusively dedicated to Huntington’s disease, has committed to continuing their ...

Point of Care Decision Support Anticoagulation Software Meets New Therapy Recommendations

ST. PAUL, Minn., Nov. 12, 2014 /PRNewswire/ -- Point of Care Anticoagulation (AC) software meets all key recommendations of a consensus statement recently published by the New York State Anticoagulation Coalition Electronic Health Record Task Force.  The task force, a multidisciplinary panel of AC specialists that includes members from IPRO (a national, non-profit organization fostering ...

Doctors Immediate Care Offering Cost-Effective Vaccination plans in Chicago Area Clinics

CHICAGO, Nov. 12, 2014 /PRNewswire/ -- Doctors Immediate Care is excited to announce vaccination plans at a reduced price during the month of November at Doctors Immediate Care clinics in Naperville, Lombard and Morton Grove Locations across Chicago Area until November 30, 2014 available from 9:00AM-9:00PM every day, 10:00AM to 6:00PM on weekends and holidays to accommodate everyone's busy sc...

Sanofi-Regeneron's asthma candidate performs well in Phase II trial

Sanofi and Regeneron plan to initiate Phase III trials of their experimental monoclonal antibody drug dupilumab after obtaini -More- 

Heartburn Center of California raising awareness about GERD during 16th Annual National GERD AWARENESS WEEK, November 23-29th

Gastroesophageal Reflux Disiease (GERD), a lifelong disease affecting up to one in five adults in the United States Walnut Creek, CA (PRWEB) November 12, 2014 National GERD Awareness week takes place every year during the week of Thanksgiving – a time when many Americans may experience heartburn associated with overeating. However, if heartburn occurs more frequently, or is associated with sym...

Tuesday 11th November 2014

Sanofi and Regeneron report positive Phase IIb trial results of dupilumab in asthma patients

Sanofi and Regeneron Pharmaceuticals have reported positive results from the interim analysis of a dose-ranging Phase IIb trial of dupilumab, a fully-human monoclonal antibody, in adult patients with uncontrolled moderate-to-severe asthma.

Survey Finds Quality of Food Top Concern for Parents When It Comes to School Lunch

Artificial sweeteners, high fructose corn syrup, hormones and antibiotics top the list of ingredients parents want removed from school menus according to Life Time Foundation survey Every day, school lunch programs across the country are focused on numbers—from limiting the number of calories, sodium and fat, to ensuring the right number of servings ...

Regeneron, Sanofi plannning dupilumab Phase III in asthma

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and partner Sanofi (Euronext:SAN; NYSE:SNY) said they plan to run a Phase III trial of dupilumab to treat adults with uncontrolled moderate-to-severe asthma after interim Phase IIb data showed the three hi...

Bacterial or Viral Lung Infection? UPMC Studying Blood Test That Could Reduce Antibiotic Use

A new blood biomarker test that indicates whether bacteria is the cause of a patient’s lung infection is now being studied at the University of Pittsburgh Medical Center, launching a national multicenter trial. Pittsburgh, Pennsylvania (PRWEB) November 11, 2014 A new blood biomarker test that indicates whether bacteria is the cause of a patient’s lung infection is now being studied at UPMC Pr...

Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis

THOUSAND OAKS, Calif. and LONDON, Nov. 11, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and AstraZeneca (NYSE: AZN) today announced that AMAGINE-3TM, a pivotal, multi-arm Phase 3 trial evaluating two doses of brodalumab in more than 1,800 patients with moderate-to-severe plaque psoriasis, met its primary endpoints when compared with both Stelara® (ustekinumab) and placebo at week 12. Brodalumab ...

KaloBios Announces Upcoming Scientific and Investor Conference Participation

SOUTH SAN FRANCISCO, Calif., Nov. 11, 2014 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that it will present at the Stifel 2014 Healthcare Conference in November, and that data on the company's KB004 program in hematologic malignancies will be presented in a poster session at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition in early ...

Multi Radiance Medical Announces a Significant Published Study on MR4 Super Pulsed Laser Technology and Its Effects on COPD

Multi Radiance Medical announces the publication of a recent clinical study about the impact of the MR4 Super Pulsed Laser on the exercise in patients with Chronic Obstructive Pulmonary Disease (COPD). The study was conducted by Dr. Eduardo Miranda, PhD and has been accepted for publication without revisions by the peer reviewed Lasers in Medical Science. ...

IGPA CALLS FOR EQUAL STATUS FOR GENERICS INDUSTRY AT GLOBAL PHARMACEUTICAL STANDARDS ORGANIZATION MEETING

11 November 2014: Nottingham, UK:  Copley Scientific will be displaying the smart new Facemask Testing Apparatus for metered dose inhaler (MDI) testing, in accordance with a recently released draft US Pharmacopoeia (USP) chapter, at Drug Delivery to the Lungs 25 (DDL 25). DDL 25 takes place in the Edinburgh International Conference Centre, Scotland, from 10th to 12th December 2014. Also ...

Asthma Partnering 2009-2014 - Edition 1 - CP2213ast

Recently added to the BioPortfolio report store, Asthma Partnering 2009-2014 - Edition 1 - CP2213ast is a new report from Current Partnering published on 2014-10-31. This 100+-page report is available from $995. The Asthma Partnering 2009-2014 report provides understanding and access to the asthma partnering deals and agreements entered into by the worlds leading healthcare companiesThe Asthma P...

Idiopathic Pulmonary Fibrosis Partnering 2009-2014 - Edition 1 - CP2213idi

Recently added to the BioPortfolio report store, Idiopathic Pulmonary Fibrosis Partnering 2009-2014 - Edition 1 - CP2213idi is a new report from Current Partnering published on 2014-10-31. This 100+-page report is available from $695. The Idiopathic Pulmonary Fibrosis Partnering 2009-2014 report provides understanding and access to the idiopathic pulmonary fibrosis partnering deals and agreement...

Musculoskeletal Symptoms Partnering 2009-2014 - Edition 1 - CP2215sym

Recently added to the BioPortfolio report store, Musculoskeletal Symptoms Partnering 2009-2014 - Edition 1 - CP2215sym is a new report from Current Partnering published on 2014-10-31. This 100+-page report is available from $695. The Musculoskeletal Symptoms Partnering 2009-2014 report provides understanding and access to the musculoskeletal symptoms partnering deals and agreements entered into ...

Osteoporosis Partnering 2009-2014 - Edition 1 - CP2215ost

Recently added to the BioPortfolio report store, Osteoporosis Partnering 2009-2014 - Edition 1 - CP2215ost is a new report from Current Partnering published on 2014-10-31. This 100+-page report is available from $695. The Osteoporosis Partnering 2009-2014 report provides understanding and access to the osteoporosis partnering deals and agreements entered into by the worlds leading healthcare com...

Bone Fracture Partnering 2009-2014 - Edition 1 - CP2215bon

Recently added to the BioPortfolio report store, Bone Fracture Partnering 2009-2014 - Edition 1 - CP2215bon is a new report from Current Partnering published on 2014-10-31. This 100+-page report is available from $695. The Bone Fracture Partnering 2009-2014 report provides understanding and access to the bone fracture partnering deals and agreements entered into by the worlds leading healthcare ...

Muscular Dystrophy Partnering 2009-2014 - Edition 1 - CP2215mus

Recently added to the BioPortfolio report store, Muscular Dystrophy Partnering 2009-2014 - Edition 1 - CP2215mus is a new report from Current Partnering published on 2014-10-31. This 100+-page report is available from $695. The Muscular Dystrophy Partnering 2009-2014 report provides understanding and access to the muscular dystrophy partnering deals and agreements entered into by the worlds lead...

Osteoarthritis Partnering 2009-2014 - Edition 1 - CP2215oar

Recently added to the BioPortfolio report store, Osteoarthritis Partnering 2009-2014 - Edition 1 - CP2215oar is a new report from Current Partnering published on 2014-10-31. This 100+-page report is available from $695. The Osteoarthritis Partnering 2009-2014 report provides understanding and access to the osteoarthritis partnering deals and agreements entered into by the worlds leading healthca...

Sanofi/Regeneron's dupilumab shines in asthma trial

Sanofi/Regeneron's dupilumab shines in asthma trial


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks